Rhythm Pharmaceuticals Sponsors Second Annual International Meeting on Pathway-Related Obesity: Vision & Evidence (IMPROVE) 2023

-- More than 50 poster presentations highlighting new scientific developments to advance the care of people living with rare MC4R pathway diseases...

Related Keywords

France ,Boston ,Massachusetts ,United States ,Paris ,France General ,Adam Daley ,David Connolly ,Corporate Communications ,Nasdaq ,International Meeting On Pathway ,Berry Company Public Relations ,Nutriomics Laboratory ,Exchange Commission ,Rhythm Pharmaceuticals Inc ,Rhythm Pharmaceuticals ,International Meeting ,Pathway Related Obesity ,Sorbonne Universit ,Universitaires De Strasbourg ,Private Securities Litigation Reform Act ,Quarterly Report ,Investor Relations ,